West Family Investments, Inc. Takeda Pharmaceutical CO LTD Transaction History

West Family Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$12.8 - $28.65 $24,140 - $54,033	1,886 Added 9.71%	21,318 $276,000
Q2 2022 Aug 12, 2022	BUY	$13.12 - $15.03 $29,310 - $33,577	2,234 Added 12.99%	19,432 $273,000
Q1 2022 May 13, 2022	SELL	$13.54 - $15.35 $326,503 - $370,149	-24,114 Reduced 58.37%	17,198 $246,000
Q4 2021 Feb 07, 2022	BUY	$13.17 - $16.4 $193,203 - $240,587	14,670 Added 55.06%	41,312 $563,000
Q3 2021 Oct 25, 2021	SELL	$16.3 - $17.26 $502,366 - $531,953	-30,820 Reduced 53.64%	26,642 $436,000

Q2 2021 Aug 12, 2021	BUY	$16.55 - $18.64 $950,996 - $1.07 Million	57,462 New	57,462 $967,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on West Family Investments, Inc. with notifications on news.